Manufacturers Life Insurance Company, The Vaxcyte, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 157,024 shares of PCVX stock, worth $13.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
157,024
Previous 131,749 19.18%
Holding current value
$13.9 Million
Previous $9.95 Million 80.21%
% of portfolio
0.02%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$70.52 - $117.12 $1.78 Million - $2.96 Million
25,275 Added 19.18%
157,024 $17.9 Million
Q2 2024

Aug 14, 2024
BUY
$60.06 - $78.77 $760,780 - $997,779
12,667 Added 10.64%
131,749 $9.95 Million
Q1 2024

May 14, 2024
BUY
$59.79 - $81.05 $837,598 - $1.14 Million
14,009 Added 13.33%
119,082 $8.13 Million
Q4 2023

Feb 13, 2024
BUY
$45.35 - $63.41 $555,492 - $776,709
12,249 Added 13.2%
105,073 $6.6 Million
Q3 2023

Nov 15, 2023
BUY
$46.0 - $53.1 $512,210 - $591,268
11,135 Added 13.63%
92,824 $4.73 Million
Q2 2023

Aug 11, 2023
BUY
$34.66 - $54.07 $1.84 Million - $2.88 Million
53,192 Added 186.66%
81,689 $4.08 Million
Q1 2023

May 15, 2023
BUY
$36.27 - $47.2 $16,793 - $21,853
463 Added 1.62%
28,960 $1.09 Million
Q4 2022

Aug 11, 2023
BUY
$20.58 - $47.95 $159,577 - $371,804
7,754 Added 37.38%
28,497 $1.37 Million
Q4 2022

Feb 13, 2023
BUY
$20.58 - $47.95 $159,577 - $371,804
7,754 Added 37.38%
28,497 $1.37 Million
Q3 2022

Aug 11, 2023
SELL
$21.69 - $28.53 $281 - $370
-13 Reduced 0.06%
20,743 $497,000
Q3 2022

Nov 03, 2022
SELL
$21.69 - $28.53 $281 - $370
-13 Reduced 0.06%
20,743 $498,000
Q2 2022

Aug 11, 2023
BUY
$17.68 - $26.58 $57,406 - $86,305
3,247 Added 18.54%
20,756 $451,000
Q2 2022

Aug 15, 2022
BUY
$17.68 - $26.58 $57,406 - $86,305
3,247 Added 18.54%
20,756 $452,000
Q1 2022

Aug 11, 2023
SELL
$17.46 - $26.36 $199,934 - $301,848
-11,451 Reduced 39.54%
17,509 $422,000
Q1 2022

May 20, 2022
SELL
$17.46 - $26.36 $69,333 - $104,675
-3,971 Reduced 18.49%
17,509 $423,000
Q4 2021

Feb 16, 2022
BUY
$19.32 - $26.45 $1,951 - $2,671
101 Added 0.47%
21,480 $511,000
Q3 2021

Nov 12, 2021
SELL
$20.26 - $26.97 $30,572 - $40,697
-1,509 Reduced 6.59%
21,379 $542,000
Q2 2021

Aug 12, 2021
BUY
$16.45 - $24.06 $102,796 - $150,350
6,249 Added 37.56%
22,888 $515,000
Q1 2021

May 03, 2021
BUY
$18.66 - $29.16 $100,372 - $156,851
5,379 Added 47.77%
16,639 $329,000
Q4 2020

Feb 12, 2021
BUY
$26.57 - $51.74 $34,461 - $67,106
1,297 Added 13.02%
11,260 $299,000
Q3 2020

Nov 09, 2020
BUY
$26.5 - $55.4 $264,019 - $551,950
9,963 New
9,963 $492,000

Others Institutions Holding PCVX

# of Institutions
357
Shares Held
123M
Call Options Held
772K
Put Options Held
430K
View Full List

About Vaxcyte, Inc.

PCVX Quotes by TradingView
  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.24B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email